VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Poraba zdravil za zdravljenje respiratornih bolezni in kašlja v pediatriji = Drug use for treatment od respiratory illnesses and cough in paediatrics
    Fürst, Jurij ; Samaluk, Vita ; Peklar, Jure
    The Slovenian health insurance list of respiratory drugs is up-to-date. In thelast 6 years the consumption of combined inhaled glucocorticoids with selective beta2 agonists, leukotriene receptor ... antagonists and anticholinergicbronchodilators has increased, while the use of inhaled glucocorticoids and selective beta2 agonists has decreased. There are significant regional differences in consumption. Age-related use is linear under the age of 19 years, after which it rises steeply. Prescribing of cough suppressants has significantly declined following the implementation of healthinsurance prescribing limitations in the year 2000. Expenditure on respiratory drugs has doubled in the last six years. Expenditure on combined inhaled glucocorticoids with selective beta2 agonists constitutes 42% of all respiratory drug expenditure. The prices of daily treatment with different respiratory drugs show great variability between comparable effective drugs.
    Vir: Zbornik (Str. 151-153)
    Vrsta gradiva - prispevek na konferenci
    Leto - 2006
    Jezik - slovenski
    COBISS.SI-ID - 21086681

vir: Zbornik (Str. 151-153)
loading ...
loading ...
loading ...